332 related articles for article (PubMed ID: 25453777)
1. Co-administration of subtherapeutic diazepam enhances neuroprotective effect of COX-2 inhibitor, NS-398, after lithium pilocarpine-induced status epilepticus.
Trandafir CC; Pouliot WA; Dudek FE; Ekstrand JJ
Neuroscience; 2015 Jan; 284():601-610. PubMed ID: 25453777
[TBL] [Abstract][Full Text] [Related]
2. Effective termination of status epilepticus by rational polypharmacy in the lithium-pilocarpine model in rats: Window of opportunity to prevent epilepsy and prediction of epilepsy by biomarkers.
Brandt C; Töllner K; Klee R; Bröer S; Löscher W
Neurobiol Dis; 2015 Mar; 75():78-90. PubMed ID: 25549873
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective effect of perampanel in lithium-pilocarpine rat seizure model.
Wu T; Ido K; Osada Y; Kotani S; Tamaoka A; Hanada T
Epilepsy Res; 2017 Nov; 137():152-158. PubMed ID: 28624183
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy.
Rigoulot MA; Koning E; Ferrandon A; Nehlig A
J Pharmacol Exp Ther; 2004 Feb; 308(2):787-95. PubMed ID: 14593082
[TBL] [Abstract][Full Text] [Related]
5. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy.
François J; Koning E; Ferrandon A; Nehlig A
Epilepsy Res; 2006 Dec; 72(2-3):147-63. PubMed ID: 16945504
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin reduces neuronal cell death in hippocampal CA1 subfield after pilocarpine-induced status epilepticus: preliminary results.
Rangel P; Cysneiros RM; Arida RM; de Albuquerque M; Colugnati DB; Scorza CA; Cavalheiro EA; Scorza FA
Arq Neuropsiquiatr; 2005 Dec; 63(4):972-6. PubMed ID: 16400415
[TBL] [Abstract][Full Text] [Related]
7. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
[TBL] [Abstract][Full Text] [Related]
8. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.
Polascheck N; Bankstahl M; Löscher W
Exp Neurol; 2010 Jul; 224(1):219-33. PubMed ID: 20353773
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus.
Li YJ; Wang L; Zhang B; Gao F; Yang CM
J Pharm Pharmacol; 2019 Mar; 71(3):390-399. PubMed ID: 30417405
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
Cunha AO; Mortari MR; Liberato JL; dos Santos WF
Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):470-7. PubMed ID: 19371260
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor inhibits hippocampal synaptic reorganization in pilocarpine-induced status epilepticus rats.
Zhang HJ; Sun RP; Lei GF; Yang L; Liu CX
J Zhejiang Univ Sci B; 2008 Nov; 9(11):903-15. PubMed ID: 18988310
[TBL] [Abstract][Full Text] [Related]
12. Differential neuroprotective effects of the NMDA receptor-associated glycine site partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and D-cycloserine in lithium-pilocarpine status epilepticus.
Peterson SL; Purvis RS; Griffith JW
Neurotoxicology; 2004 Sep; 25(5):835-47. PubMed ID: 15288514
[TBL] [Abstract][Full Text] [Related]
13. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.
André V; Rigoulot MA; Koning E; Ferrandon A; Nehlig A
Epilepsia; 2003 Jul; 44(7):893-903. PubMed ID: 12823571
[TBL] [Abstract][Full Text] [Related]
14. The mast cell stabilizer sodium cromoglycate reduces histamine release and status epilepticus-induced neuronal damage in the rat hippocampus.
Valle-Dorado MG; Santana-Gómez CE; Orozco-Suárez SA; Rocha L
Neuropharmacology; 2015 May; 92():49-55. PubMed ID: 25578265
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent.
Frisch C; Kudin AP; Elger CE; Kunz WS; Helmstaedter C
Epilepsy Res; 2007 Feb; 73(2):173-80. PubMed ID: 17084066
[TBL] [Abstract][Full Text] [Related]
17. Transition from status epilepticus to interictal spiking in a rodent model of mesial temporal epilepsy.
Wang S; Lévesque M; Avoli M
Epilepsy Res; 2019 May; 152():73-76. PubMed ID: 30913455
[TBL] [Abstract][Full Text] [Related]
18. Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model.
Rojas A; Wang W; Glover A; Manji Z; Fu Y; Dingledine R
eNeuro; 2018; 5(2):. PubMed ID: 29766039
[TBL] [Abstract][Full Text] [Related]
19. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat.
Pitkänen A; Kharatishvili I; Narkilahti S; Lukasiuk K; Nissinen J
Epilepsy Res; 2005 Jan; 63(1):27-42. PubMed ID: 15716080
[TBL] [Abstract][Full Text] [Related]
20. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat.
Rigoulot MA; Leroy C; Koning E; Ferrandon A; Nehlig A
Epilepsia; 2003 Apr; 44(4):529-35. PubMed ID: 12681001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
